Nikhil C. Munshi, MD

Video

Myeloma Patients Covid-19: How to Keep Myeloma Care Safe During the Pandemic

Nikhil Munshi, MD, discusses Covid-19 and Myeloma, the understanding the disease, how to make the treatments safer all while being aware of Covid-19 protocols.

Podcast

FDA Approval Insights: Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma

Dr. Munshi discusses the significance of the FDA approval of ide-cel in relapsed/refractory multiple myeloma, data from the KarMMa trial, which served as the basis for the approval, and next steps for CAR T-cell therapy in the field.